Polymorphic forms of (S)- tetrahydrofuran3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate

Details for Australian Patent Application No. 2006244204 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Eberlin, Alex; Parent, Stephen D.; Hurrey, Michael; Bythe, Todd A.; Jonaitis, David T.; Snoonian, John R.; Nyce, Philip L.

Agent Cullen & Co

Pub. Number AU-A-2006244204

PCT Pub. Number WO2006/122012

Priority 60/679,021 09.05.05 US

Filing date 8 May 2006

Wipo publication date 16 November 2006

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122012 Priority application(s): WO2006/122012

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244206-Bicyclic derivatives as modulators of ion channels

2006244203-Thiazole compounds and methods of use